1. Combining microfluidic chip and low-attachment culture devices to isolate oral cancer stem cells
   Hsin-Hu Chen et al, 2024, Journal of Dental Sciences CrossRef
2. Monoclonal antibody cetuximab impairs matrix metalloproteinases 2 and 9, epithelial–mesenchymal transition and cell migration in feline oral squamous cell carcinoma in vitro
   Gennaro Altamura et al, 2024, Veterinary and Comparative Oncology CrossRef
3. Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review
   Sandra López-Verdín et al, 2018, Cancers CrossRef
4. Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2
   Ying-Ju Chen et al, 2016, Oncology Letters CrossRef
5. Approaches for Head and Neck Cancer Research – Current Status and the Way Forward
   Barghavi V. et al, 2022, Cancer Investigation CrossRef
6. Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through activation of the EGFR/AKT pathway
   Yuichi OHNISHI et al, 2016, Japanese Journal of Oral and Maxillofacial Surgery CrossRef
7. An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB(+) Solid Tumor Neoplastic Cells
   Sofia K. Georgiou-Siafis et al, 2022, Biomedicines CrossRef
8. Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape
   Androulla N. Miliotou et al, 2023, Current Issues in Molecular Biology CrossRef
9. Oral Squamous Cell Carcinoma Cells with Acquired Resistance to Erlotinib Are Sensitive to Anti-Cancer Effect of Quercetin via Pyruvate Kinase M2 (PKM2)
   Chien-Yi Chan et al, 2023, Cells CrossRef
10. Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway
    YUICHI OHNISHI et al, 2015, International Journal of Oncology CrossRef
11. Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy
    A. A. Lyanova et al, 2020, Meditsinskiy sovet = Medical Council CrossRef
12. 5-Aza-CdR promotes partial MGMT demethylation and modifies expression of different genes in oral squamous cell carcinoma
    Guilherme C.L.S. do Amaral et al, 2019, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
13. STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
    O. I. Kit et al, 2019, Research and Practical Medicine Journal CrossRef
14. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders
    Gaia Viglianisi et al, 2024, Bioengineering CrossRef
15. The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence
    Tzu-Ying Lee et al, 2020, Biomolecules CrossRef
16. Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells
    Yuichi Ohnishi et al, 2017, Oncology Letters CrossRef
17. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
    Masami Nozaki et al, 2019, Cancers CrossRef
18. LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer
    Masami Nozaki et al, 2019, Oncotarget CrossRef
19. Establishment of a patient‑derived mucoepidermoid carcinoma cell line with the CRTC1‑MAML2 fusion gene
    Kazuma Noguchi et al, 2022, Molecular and Clinical Oncology CrossRef